In this white paper, you will learn what content standards are and why they are important. We introduce the Five Dimensions of Content Standardization™ and show you how our content standardization framework makes content FAIR (findable, accessible, interoperable, and reusable). Finally, we suggest some next steps that you can take
The pharma industry is no stranger to standards. Pharmaceutical companies have entire teams devoted to ensuring that all data and content is collected, created, managed, retained, and retired according to regulatory requirements.
Vigilante content is all the content created (and often distributed) by people who are not tasked with creating content. It’s the content that someone thinks up and then writes. And then publishes or emails or prints to hand out at a conference. In essence, it is unauthorized content.
Using component-based structured content authoring and having a robust reuse strategy is the only way to produce pharma content at scale. It’s how you produce accurate content efficiently across the enterprise. It’s how you deliver the right content to the right place at the right time, such as when you
The pharma industry has come together to develop technical solutions that speed time-consuming processes and reduce errors that can cause risk to the business and ultimately to patients.
In The Unique Challenges of Pharma Content, we discuss challenges faced by pharmaceutical companies in the creation and management of content.
Most content challenges are ubiquitous, present in every vertical. Processes that don’t scale. Too much content to manage and yet the exact right content never seems to be at hand. Authors must copy and paste and (inevitably) tweak content, wasting time and increasing risk. The challenges of time, cost, and
For centuries, humans have shared information through documents. We’ve used digital files, printed paper, illuminated manuscripts, parchment scrolls, and clay tablets. Regardless of form factor, a document has traditionally been created as a single monolithic entity, authored in the same format in which it was intended to be consumed.
The COVID-19 pandemic put tremendous pressure on drug-development organizations to accelerate product development far beyond anyone’s wildest roadmaps.
A reuse map is a blueprint for planned content reuse. Planned content reuse means that you identify ahead of time exactly which pieces of content will be reused in a specific output.